Dr Feliza Achacoso Alcid, MD | |
7940 Ashwood Dr Se, Ada, MI 49301-9208 | |
(616) 682-9544 | |
(616) 682-9544 |
Full Name | Dr Feliza Achacoso Alcid |
---|---|
Gender | Female |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 7940 Ashwood Dr Se, Ada, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285923045 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4301055774 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Feliza Achacoso Alcid, MD 7940 Ashwood Dr Se, Ada, MI 49301-9208 Ph: (616) 682-9544 | Dr Feliza Achacoso Alcid, MD 7940 Ashwood Dr Se, Ada, MI 49301-9208 Ph: (616) 682-9544 |
News Archive
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.
A year after a government panel revised its recommendations for breast cancer screening, many professional organizations have not followed suit.
With a better understanding of underlying mechanisms that cause a rare neurodevelopmental disorder in the Old Order Mennonite population, referred to as Pretzel syndrome, a new study reports that five children were successfully treated with a drug that modifies the disease process, minimizing seizures and improving receptive language.
The trove of data has the potential to reveal faults in drug pricing, potential fraud and could help regulators and consumers track medical spending - but could take years to sort out.
Imagine smart materials that can morph from being stiff as wood to as soft as a sponge - and also change shape.
› Verified 6 days ago